Works matching AU Van de Donk, Niels

Results: 66

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02134

By:

van de Donk, Niels W.C.J.;
Usmani, Saad Z.

Publication type:

Article

Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design.

Published in:

PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197349

By:

Drent, Esther;
Poels, Renée;
Mulders, Manon J.;
van de Donk, Niels W. C. J.;
Themeli, Maria;
Lokhorst, Henk M.;
Mutis, Tuna

Publication type:

Article

The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review.

Published in:

2021

By:

Slot, Stefanie;
van de Donk, Niels W. C. J.;
Otten, René H. J.;
Boden, Bouke J. H.;
Zijlstra, Josée;
Raijmakers, Pieter G. H. M.;
Zweegman, Sonja

Publication type:

journal article

Advances in minimal residual disease monitoring in multiple myeloma.

Published in:

Critical Reviews in Clinical Laboratory Sciences, 2023, v. 60, n. 7, p. 518, doi. 10.1080/10408363.2023.2209652

By:

Wijnands, Charissa;
Noori, Somayya;
Donk, Niels W. C. J. van de;
VanDuijn, Martijn M.;
Jacobs, Joannes F. M.

Publication type:

Article

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?

Published in:

Cells (2073-4409), 2020, v. 9, n. 2, p. 378, doi. 10.3390/cells9020378

By:

Plesner, Torben;
van de Donk, Niels W. C. J.;
Richardson, Paul G.

Publication type:

Article

Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance: Cumulative Incidence and Prognostic Factors.

Published in:

Leukemia & Lymphoma, 2001, v. 42, n. 4, doi. 10.3109/10428190109099321

By:

Van De Donk, Niels;
De Weerdt, Okke;
Eurelings, Marijke;
Bloem, Andries;
Lokhorst, Henk

Publication type:

Article

Acute and chronic renal artery stenosis.

Published in:

European Heart Journal, 2010, v. 31, n. 1, p. 14, doi. 10.1093/eurheartj/ehp455

By:

van de Donk, Niels W.C.J.;
Kooij, Nina;
Visseren, Frank L.J.

Publication type:

Article

Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy.

Published in:

2001

By:

Eurelings, Marijke;
Notermans, Nicolette C.;
Van de Donk, Niels W.C.J.;
Lokhorst, Henk M.;
Eurelings, M;
Notermans, N C;
Van de Donk, N W;
Lokhorst, H M

Publication type:

journal article

High‐dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma.

Published in:

British Journal of Haematology, 2022, v. 196, n. 6, p. e67, doi. 10.1111/bjh.17980

By:

Aydin, Mesire;
Tang, Man Wai;
Wondergem, Mariëlle J.;
de Leeuw, David C.;
Wegman, Jurgen J.;
Biemond, Bart J.;
van de Donk, Niels W. C. J.;
Zweegman, Sonja;
Meijer, Ellen;
Nur, Erfan

Publication type:

Article

Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

Published in:

British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338

By:

Rosiñol, Laura;
Beksac, Meral;
Zamagni, Elena;
Van de Donk, Niels W. C. J.;
Anderson, Kenneth C.;
Badros, Ashraf;
Caers, Jo;
Cavo, Michele;
Dimopoulos, Meletios‐Athanasios;
Dispenzieri, Angela;
Einsele, Hermann;
Engelhardt, Monika;
Fernández de Larrea, Carlos;
Gahrton, Gösta;
Gay, Francesca;
Hájek, Roman;
Hungria, Vania;
Jurczyszyn, Artur;
Kröger, Nicolaus;
Kyle, Robert A.

Publication type:

Article

Loss of vision as the first manifestation of amyloid light‐chain amyloidosis.

Published in:

2024

By:

van de Donk, Niels W. C. J.;
Huysentruyt, Clément;
Dhooge, Mario R. P.

Publication type:

Case Study

T‐cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions.

Published in:

EJHaem, 2023, v. 4, n. 3, p. 811, doi. 10.1002/jha2.729

By:

O'Neill, Chloe;
van de Donk, Niels W. C. J.

Publication type:

Article

Waldenström macroglobulinemia presenting as nephrotic syndrome: Renal heavy and light chain amyloidosis.

Published in:

EJHaem, 2022, v. 3, n. 2, p. 565, doi. 10.1002/jha2.424

By:

Kwakernaak, Arjan J.;
Bernelot Moens, Sophie J.;
Hilhorst, Marc L.;
Florquin, Sandrine;
van de Donk, Niels W.C.J.;
Vos, Josephine M.I.

Publication type:

Article

Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.

Published in:

Science Translational Medicine, 2021, v. 13, n. 623, p. 1, doi. 10.1126/scitranslmed.abh1962

By:

Katsarou, Afroditi;
Sjöstrand, Maria;
Naik, Jyoti;
Mansilla-Soto, Jorge;
Kefala, Dionysia;
Kladis, Georgios;
Nianias, Alexandros;
Ruiter, Ruud;
Poels, Renée;
Sarkar, Irene;
Patankar, Yash R.;
Merino, Elena;
Reijmers, Rogier M.;
Frerichs, Kristine A.;
Yuan, Huipin;
de Bruijn, Joost;
Stroopinsky, Dina;
Avigan, David;
van de Donk, Niels W. C. J.;
Zweegman, Sonja

Publication type:

Article

Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 665, doi. 10.1016/j.clml.2024.05.003

By:

Chari, Ajai;
Krishnan, Amrita;
Rasche, Leo;
Ye, Jing Christine;
Garfall, Alfred;
Popat, Rakesh;
Lipe, Brea;
Qin, Xiang;
Campagna, Michela;
Masterson, Tara;
Tomlinson, Chalmer;
Hilder, Brandi;
Tolbert, Jaszianne;
Renaud, Thomas;
Smit, M. Damiette;
Gray, Kathleen;
Kane, Colleen;
Heuck, Christoph;
Donk, Niels W.C.J. van de

Publication type:

Article

Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 350, doi. 10.1016/j.clml.2024.03.005

By:

Raje, Noopur S.;
Cohen, Adam D.;
Patel, Krina K.;
de Donk, Niels W.C.J. van;
Richter, Joshua;
San-Miguel, Jesus

Publication type:

Article

Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 413, doi. 10.1016/j.clml.2023.03.009

By:

Terpos, Evangelos;
Neri, Paola;
van de Donk, Niels W.C.J.;
D'Agostino, Mattia;
Parekh, Samir;
Jagannath, Sundar;
Ludwig, Heinz;
Avigan, David E.;
Dhodapkar, Madhav V.;
Raje, Noopur S.

Publication type:

Article

P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2

By:

Lonial, Sagar;
Berdeja, Jesus G.;
Dimopoulos, Meletios-Athanasios;
Jagannath, Sundar;
Knop, Stefan;
Hang Quach;
Rodríguez-Otero, Paula;
Richardson, Paul G.;
Sorrell, April;
Min Chen;
Kueenburg, Elisabeth;
Tuong Vi Nguyen;
Hong, Kevin;
Peluso, Teresa;
van de Donk, Niels W.C.J.

Publication type:

Article

P-155: Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S120, doi. 10.1016/S2152-2650(21)02282-5

By:

Einsele, Hermann;
Parekh, Samir;
Madduri, Deepu;
Santomasso, Bianca;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W.C.J.;
Arnulf, Bertrand;
Mateos, María-Victoria;
De Braganca, Kevin C.;
Varsos, Helen;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Zudaire, Enrique;
Li, Claire;
Dong Geng;
Jakubowiak, Andrzej;
Cohen, Adam

Publication type:

Article

OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5

By:

Lonial, Sagar;
Richardson, Paul G.;
Popat, Rakesh;
Stadtmauer, Edward A.;
Larsen, Jeremy T.;
Oriol, A.;
Knop, Stefan;
Jagannath, Sundar;
Cook, Gordon;
Badros, Ashraf Z.;
Rodríguez-Otero, Paula;
Siegel, David S.;
Tuong Vi Nguyen;
Micco, Antonia Di;
Amin, Alpesh;
Min Chen;
Kueenburg, Elisabeth;
van de Donk, Niels W.C.J.

Publication type:

Article

OAB-025: Talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D)×CD3 bispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results of a phase 1, first-in-human study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S16, doi. 10.1016/S2152-2650(21)02099-1

By:

Donk, Niels W.C.J. van de;
Krishnan, Amrita;
Oriol, A;
Berdeja, Jesus G.;
Rodríguez-Otero, Paula;
Askari, Elham;
Mateos, María-Victoria;
Minnema, Monique C.;
Costa, Luciano;
Verona, Raluca;
Girgis, Suzette;
Prior, Thomas;
Hilder, Brandi;
Russell, Jeffery;
Goldberg, Jenna;
Chari, Ajai

Publication type:

Article

OAB-008: Identification of high-risk Multiple Myeloma with a plasma cell Leukemia-like transcriptomic profile.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02082-6

By:

Bruinink, Davine Hofste op;
Kuiper, Rowan;
Duin, Mark van;
Cupedo, Tom;
Velden, Vincent H.J. van der;
Hoogenboezem, Remco;
Holt, Bronno van der;
Beverloo, H. Berna;
Valent, Erik T.;
Vermeulen, Michael;
Gay, Francesca;
Broijl, Annemiek;
Avet-Loiseau, Hervé;
Munshi, Nikhil C.;
Musto, Pellegrino;
Moreau, Philippe;
Zweegman, Sonja;
Donk, Niels W.C.J. van de;
Sonneveld, Pieter

Publication type:

Article

MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01945-5

By:

Jakubowiak, Andrzej;
Parekh, Samir;
Madduri, Deepu;
Santomasso, Bianca;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W.C.J.;
Arnulf, Bertrand;
Mateos, Maria-Victoria;
De Braganca, Kevin C.;
Varsos, Helen;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Zudaire, Enrique;
Li, Claire;
Geng, Dong;
Einsele, Hermann;
Cohen, Adam

Publication type:

Article

Poster: MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01568-8

By:

Jakubowiak, Andrzej;
Parekh, Samir;
Madduri, Deepu;
Santomasso, Bianca;
Pérez-Larraya, Jaime Gállego;
van de Donk, Niels W.C.J.;
Arnulf, Bertrand;
Mateos, Maria-Victoria;
De Braganca, Kevin C.;
Varsos, Helen;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lendvai, Nikoletta;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Zudaire, Enrique;
Li, Claire;
Geng, Dong;
Einsele, Hermann;
Cohen, Adam

Publication type:

Article

Pomalidomide and Dexamethasone Treatment for ≥ 1 Year in Renally Impaired Patients With Relapsed or Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e284, doi. 10.1016/j.clml.2019.09.468

By:

Weisel, Katja;
Dimopoulos, Meletios A.;
Cook, Mark;
Ramasamy, Karthik;
Rubia, Javier De La;
Ardizzoia, Antonio;
Krauth, Maria Theresa;
JACCARD, Arnaud;
Van de Donk, Niels;
Kueenburg, Elisabeth;
Di Micco, Antonia;
Rosettani, Barbara;
Atiba-Davies, Margaret;
Bacon, Pamela;
Sonneveld, Pieter

Publication type:

Article

Preclinical evaluation of the new GPRC5DxCD3 (JNJ-7564) bispecific antibody for the treatment of multiple myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e122, doi. 10.1016/j.clml.2019.09.202

By:

Verkleij, Christie;
Broekmans, Marloes;
van Duin, Mark;
Frerichs, Kristine;
Kuiper, Rowan;
Kaiser, Martin;
Morgan, Gareth;
Axel, Amy;
Chiu, Chris;
Sonneveld, Pieter;
Zweegman, Sonja;
Adams III, Homer;
Mutis, Tuna;
Van de Donk, Niels

Publication type:

Article

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e52, doi. 10.1016/j.clml.2019.09.080

By:

Lonial, Sagar;
Van de Donk, Niels;
Popat, Rakesh;
Zonder, Jeffrey A.;
Minnema, Monique;
Larsen, Jeremy T.;
Nguyen, Tuong Vi;
Chen, Min S.;
Bensmaine, Amine;
Peluso, Teresa;
Sonneveld, Pieter

Publication type:

Article

Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e3, doi. 10.1016/j.clml.2019.09.005

By:

Avet-Loiseau, Herve;
Bene, Marie C.;
Wuilleme, Soraya;
Corre, Jill;
Attal, Michel;
Arnulf, Bertrand;
Garderet, Laurent;
Macro, Margaret;
Stoppa, Anne-Marie;
Delforge, Michel;
Broijl, Annemiek;
Zweegman, Sonja;
Jie, Kon-Siong;
Van de Donk, Niels;
Pei, Lixia;
de Boer, Carla;
Chiu, Chris;
Vanquickelberghe, Véronique;
Kampfenkel, Tobias;
Vermeulen, Jessica

Publication type:

Article

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment.

Published in:

2019

By:

Frerichs, Kristine A.;
Bosman, Patricia W.C.;
Nijhof, Inger S.;
Zweegman, Sonja;
van de Donk, Niels W.C.J.

Publication type:

journal article

Phase 2 Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): An Updated Safety Analysis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e145, doi. 10.1016/j.clml.2017.03.261

By:

Weisel, Katja;
Dimopoulos, Meletios Athanasios;
Van de Donk, Niels;
Ramasamy, Karthik;
Gamberi, Barbara;
Streetly, Matthew;
Offidani, Massimo;
Bridoux, Frank;
Rubia, Javier de la;
Kueenburg, Elisabeth;
Collins, Shona;
Lersch, Frederik;
Rosettani, Barbara;
Bacon, Pamela;
Sonneveld, Pieter

Publication type:

Article

Brentuximab vedotin.

Published in:

mAbs (1942-0862), 2012, v. 4, n. 4, p. 458, doi. 10.4161/mabs.20230

By:

van de Donk, Niels W. C. J.;
Dhimolea, Eugen

Publication type:

Article

Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients.

Published in:

Cancers, 2021, v. 13, n. 10, p. 2452, doi. 10.3390/cancers13102452

By:

Frerichs, Kristine A.;
Verkleij, Christie P. M.;
Dimopoulos, Meletios A.;
Marin Soto, Jhon A.;
Zweegman, Sonja;
Young, Mary H.;
Newhall, Kathryn J.;
Mutis, Tuna;
van de Donk, Niels W. C. J.;
Limagn, Emeric;
Vallet, Sonia

Publication type:

Article

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma.

Published in:

Cancers, 2021, v. 13, n. 7, p. 1571, doi. 10.3390/cancers13071571

By:

Radocha, Jakub;
van de Donk, Niels W. C. J.;
Weisel, Katja;
Ocio, Enrique M.

Publication type:

Article

Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies.

Published in:

Cancers, 2020, v. 12, n. 12, p. 3713, doi. 10.3390/cancers12123713

By:

Verkleij, Christie P. M.;
Jhatakia, Amy;
Broekmans, Marloes E. C.;
Frerichs, Kristine A.;
Zweegman, Sonja;
Mutis, Tuna;
Bezman, Natalie A.;
van de Donk, Niels W. C. J.

Publication type:

Article

T-cell redirecting bispecific antibody treatment in multiple myeloma: current knowledge and future strategies for sustained T-cell engagement.

Published in:

Expert Opinion on Biological Therapy, 2024, v. 24, n. 9, p. 889, doi. 10.1080/14712598.2024.2397436

By:

Heerma van Voss, Marise R.;
Molenaar, Remco J.;
Korst, Charlotte L. B. M.;
Bartelink, Imke H.;
Baglio, Serena R.;
Kruyswijk, Sandy;
de Ruijter, Maaike;
Zweegman, Sonja;
Kuipers, Maria T.;
van de Donk, Niels W. C. J.

Publication type:

Article

Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study.

Published in:

Cancer (0008543X), 2024, v. 130, n. 6, p. 886, doi. 10.1002/cncr.35107

By:

Nooka, Ajay K.;
Rodriguez, Cesar;
Mateos, María Victoria;
Manier, Salomon;
Chastain, Katherine;
Banerjee, Arnob;
Kobos, Rachel;
Qi, Keqin;
Verona, Raluca;
Doyle, Margaret;
Martin, Thomas G.;
van de Donk, Niels W. C. J.

Publication type:

Article

Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma.

Published in:

Cancer (0008543X), 2023, v. 129, n. 13, p. 2035, doi. 10.1002/cncr.34756

By:

Martin, Thomas G.;
Mateos, Maria Victoria;
Nooka, Ajay;
Banerjee, Arnob;
Kobos, Rachel;
Pei, Lixia;
Qi, Ming;
Verona, Raluca;
Doyle, Margaret;
Smit, Jennifer;
Sun, Weili;
Trancucci, Danielle;
Uhlar, Clarissa;
van de Donk, Niels W. C. J.;
Rodriguez, Cesar

Publication type:

Article

Targeted Therapy With Immunoconjugates for Multiple Myeloma.

Published in:

Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01155

By:

Bruins, Wassilis S. C.;
Zweegman, Sonja;
Mutis, Tuna;
van de Donk, Niels W. C. J.

Publication type:

Article

Immunotherapy in myeloma: how far have we come?

Published in:

Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718822660

By:

Franssen, Laurens E.;
Mutis, Tuna;
Lokhorst, Henk M.;
van de Donk, Niels W. C. J.

Publication type:

Article

Lenalidomide for the treatment of relapsed and refractory multiple myeloma.

Published in:

Cancer Management & Research, 2012, v. 4, p. 253, doi. 10.2147/CMAR.S27087

By:

Van de Donk, Niels W. C. J.;
Görgün, Güllü;
Groen, Richard W. J.;
Jakubikova, Jana;
Mitsiades, Constantine S.;
Hideshima, Teru;
Laubach, Jacob;
Nijhof, Inger S.;
Raymakers, Reinier A.;
Lokhorst, Henk M.;
Richardson, Paul G.;
Anderson, Kenneth C.

Publication type:

Article

Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma.

Published in:

2010

By:

van de Donk, Niels W. C. J.;
Wittebol, Shulamit;
Minnema, Monique C.;
Lokhorst, Henk M.

Publication type:

Letter

CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience.

Published in:

Expert Review of Clinical Immunology, 2018, v. 14, n. 3, p. 197, doi. 10.1080/1744666X.2018.1443809

By:

Frerichs, Kristine A.;
Nagy, Noemi Anna;
Lindenbergh, Pieter L.;
Bosman, Patty;
Marin Soto, Jhon;
Broekmans, Marloes;
Groen, Richard W. J.;
Themeli, Maria;
Nieuwenhuis, Louise;
Stege, Claudia;
Nijhof, Inger S.;
Mutis, Tuna;
Zweegman, Sonja;
Lokhorst, Henk M.;
van de Donk, Niels W. C. J.

Publication type:

Article

Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4593, doi. 10.3390/jcm10194593

By:

Hosny, Mashhour;
Verkleij, Christie P. M.;
van der Schans, Jort;
Frerichs, Kristine A.;
Mutis, Tuna;
Zweegman, Sonja;
van de Donk, Niels W. C. J.

Publication type:

Article

Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1195, doi. 10.3390/jcm9041195

By:

Franssen, Laurens E.;
Stege, Claudia A. M.;
Zweegman, Sonja;
van de Donk, Niels W. C. J.;
Nijhof, Inger S.

Publication type:

Article

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference.

Published in:

Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 12, p. 1963, doi. 10.1515/cclm-2021-0399

By:

Noori, Somayya;
Verkleij, Christie P. M.;
Zajec, Marina;
Langerhorst, Pieter;
Bosman, Patricia W. C.;
de Rijke, Yolanda B.;
Zweegman, Sonja;
VanDuijn, Martijn;
Luider, Theo;
van de Donk, Niels W. C. J.;
Jacobs, Joannes F. M.

Publication type:

Article

Response to: Interference of daratumumab on the serum protein electrophoresis.

Published in:

Clinical Chemistry & Laboratory Medicine, 2017, v. 55, n. 2, p. e29, doi. 10.1515/cclm-2016-1026

By:

McCudden, Christopher;
Axel, Amy E.;
Slaets, Dominique;
Dejoie, Thomas;
Clemens, Pamela;
Frans, Sandy;
Bald, Jaime;
Plesner, Torben;
Jacobs, Joannes F.M.;
van de Donk, Niels W.C.J.;
Moreau, Philippe;
Schecter, Jordan M.;
Ahmadi, Tahamtan;
Sasser, A. Kate

Publication type:

Article

Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference.

Published in:

Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 6, p. 1095, doi. 10.1515/cclm-2015-1031

By:

McCudden, Christopher;
Axel, Amy E.;
Slaets, Dominique;
Dejoie, Thomas;
Clemens, Pamela L.;
Frans, Sandy;
Bald, Jaime;
Plesner, Torben;
Jacobs, Joannes F. M.;
van de Donk, Niels W. C. J.;
Moreau, Philippe;
Schecter, Jordan M.;
Ahmadi, Tahamtan;
Kate Sasser, A.

Publication type:

Article

Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).

Published in:

2016

By:

van de Donk, Niels W. C. J.;
Otten, Henny G.;
El Haddad, Omar;
Axel, Amy;
Sasser, A. Kate;
Croockewit, Sandra;
Jacobs, Joannes F. M.

Publication type:

Case Study

Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01160-1

By:

van de Donk, Niels W. C. J.;
Bahlis, Nizar;
Costa, Luciano J.;
Mateos, María-Victoria;
Nooka, Ajay K.;
Perrot, Aurore;
Garfall, Alfred L.;
Thaman, Pragya;
Qi, Keqin;
Uhlar, Clarissa;
Chastain, Katherine;
Doyle, Margaret;
Usmani, Saad Z.

Publication type:

Article

GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00966-9

By:

Rodriguez-Otero, Paula;
van de Donk, Niels W. C. J.;
Pillarisetti, Kodandaram;
Cornax, Ingrid;
Vishwamitra, Deeksha;
Gray, Kathleen;
Hilder, Brandi;
Tolbert, Jaszianne;
Renaud, Thomas;
Masterson, Tara;
Heuck, Christoph;
Kane, Colleen;
Verona, Raluca;
Moreau, Philippe;
Bahlis, Nizar;
Chari, Ajai

Publication type:

Article